About Access Vascular
Access Vascular is a Healthcare company based in Bedford (United States) founded in 2015 by James Biggins. Hydrogel-based devices are developed for improved venous access. Access Vascular has raised $54.29 million across 8 funding rounds from investors including TVM Capital Life Science. Its chief executive, as recorded, is James Biggins. Access Vascular offers products and services including HydroPICC, HydroMID, and MIMIX Technology. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is Access Vascular, Inc. Its competitors include Cardival Medical, Aziyo Biologics and EKOS Corporation; 3 of its 3 listed competitors have raised funding.
Company details
Access Vascular was founded in 2015 and is based in Bedford, United States. Hydrogel-based medical devices are developed by the company to enhance venous access and mitigate complications such as thrombus buildup, occlusions, and infections. The HydroPICC, a peripherally inserted central catheter, utilizes proprietary biomaterial to reduce thrombotic responses. A dialysis catheter is also under development, alongside evaluations of the materials drug delivery potential in the vascular sector.
- Headquarters Bedford, United States
- Founders James Biggins
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website accessvascularinc.com
- Social LinkedIn X YouTube
- Legal Name Access Vascular, Inc.
- Total Equity Funding$54.29M (USD)
in 8 rounds
- Latest Funding Round$22M (USD), Series C
Oct 2023
- Investors
Products & Services of Access Vascular
Access Vascular offers a comprehensive portfolio of products and services, including HydroPICC, HydroMID, and MIMIX Technology.
Vascular access device that reduces complications like thrombosis in patients.
Midline catheter using MIMIX technology to prevent occlusions and replacements.
Hydrophilic material designed to minimize vascular access complications effectively.
Apps and channels of Access Vascular
its YouTube channel Access Vascular has 20 subscribers and 19 videos.
Videos from Access Vascular
The most watched videos on Access Vascular's YouTube channel, Access Vascular (20 subscribers). Click a video to play it here.
More on Access Vascular.
Funding Insights of Access Vascular
Access Vascular has successfully raised a total of $54.29M across 8 strategic funding rounds. The most recent funding activity was a Series C round of $22 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $54.29M
- Total Rounds 8
- Last Round Series C — $22M
- First Round $3.77M
(Aug 2017)
- Investors Count 1
All 8 funding rounds of Access Vascular with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | Debt – Conventional | – | – | – | |
| Oct 2023 | $22M | Series C | – | – | – |
| Mar 2021 | Debt – Conventional | – | – | – | |
| Mar 2021 | $20M | Series B | – | TVM Capital Life Science | – |
| Sep 2019 | $6M | Series A | – | – | – |
| Oct 2018 | $594,000 | Series A | – | – | – |
| May 2018 | $1.92M | Series A | – | – | – |
| Aug 2017 | $3.77M | Angel Round | – | – | – |
1 investors in total: 1 institutional.
Investors in Access Vascular
Access Vascular has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include TVM Capital Life Science.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life Science focused early stage VC firm investing in Europe, Canada, the USA and Asia | tvm-lifescience.com | Munich, Germany |
Investor details for Access Vascular
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Access Vascular
15 people are tracked at Access Vascular (6 in leadership, 5 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
James Biggins | Founder & CEO | Leadership |
Dennis Byrne | Chief Commercial Officer (cco) | Leadership |
Katie Motherway | Vice President Human Resources | Leadership |
Kristen LeRoy | Director Of R&d | Leadership |
Mike McGrath | Director Of Operations | Leadership |
Scott Blood | Vice President Of Quality And Regulatory | Leadership |
Marc Riviere | Director | Board & advisors |
Michael R. Jaff | Director | Board & advisors |
Luc Marengere | Director | Board & advisors |
Amine Bentaleb | Director | Board & advisors |
Paul Sabin | Director | Board & advisors |
Glen Mehring | Southeast Area Sales Manager | Team |
Jeff Gaus | National Sales Manager | Team |
George Michaels | Principal Engineer | Team |
Jacob Brenza | Principal R&d Engineer | Team |
Complete people profiles for Access Vascular
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Access Vascular
3 dated milestones of Access Vascular across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Access Vascular is founded.
- Funding First funding round of $3.8M.
- Funding Latest funding round, Series C, of $22.0M.
Competitors of Access Vascular
Access Vascular has 3 listed competitors in our database, 3 of them funded. They include Cardival Medical, Aziyo Biologics and EKOS Corporation.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cardivamedical.com | 2002 | Santa Clara, United States | $169.45M | 158 | A device for vascular access management is developed. | |
| aziyo.com | 2015 | Silver Spring, United States | $49.59M | 162 | Regenerative medicine products are developed for orthopedic and cardiovascular applications. | |
| ekoscorp.com | 1995 | Bothell, United States | $58.8M | Ultrasound thrombolytic devices for pulmonary embolism treatment are developed. |
Detailed competitors of Access Vascular
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Access Vascular
The website of Access Vascular (accessvascularinc.com) receives about 5.5K visits a month.
- Monthly visits5.5K
▲ 19.4% vs previous month
Websites whose visitors overlap most with Access Vascular. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| scientiavascular.com | 100% | 2.3K | #7,396,634 | View details | |
| unetixs.com | 96% | 1.6K | #10,876,348 | View details |
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Access Vascular (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Access Vascular
Complete news archive for Access Vascular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Access Vascular
Access Vascular was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Access Vascular is headquartered in Bedford, United States.
James Biggins is the CEO of Access Vascular, as recorded in our data. They have also founded this company.
Access Vascular is a funded company, having raised a total of $54.29M across 8 funding rounds to date. The company's 1st funding round was a Angel Round of $3.77M, raised on Aug 2017.
Access Vascular was founded in 2015 and is based in Bedford, United States. Hydrogel-based medical devices are developed by the company to enhance venous access and mitigate complications such as thrombus buildup, occlusions, and infections. The HydroPICC, a peripherally inserted central catheter, utilizes proprietary biomaterial to reduce thrombotic responses. A dialysis catheter is also under development, alongside evaluations of the materials drug delivery potential in the vascular sector.
Access Vascular's top competitors include Cardival Medical, Aziyo Biologics and EKOS Corporation.
Access Vascular offers HydroPICC, HydroMID, and MIMIX Technology.
Access Vascular has 1 investor. Key investors include TVM Capital Life Science.
Access Vascular operates through Access Vascular, Inc..